Great ISAMs

Organizers Jim Fink and Andy Clark, together with visitor John Patton, look back at the 2021 ISAM congress in Boise, Idaho. Which took place in the middle of the SARSCov19 pandemic. Listen how they organized a hybrid event with live visitors from the US (with enough space to stick to the social distancing standards) and a lot of virtual visitors from around the globe. This podcast episode also highlights that for several ISAM members the pandemic was a special period, where many of us engaged in developing medicinal treatments and inhaled vaccines.

Creators and Guests

WK
Host
Wilbur de Kruijf
ISAM Board Member and developer of inhaled products in the pharmaceutical industry. Director inhalation technology at United Therapeutics Netherlands BV.
AC
Guest
Andy Clark
Andy is serving "40 years to life" in pulmonary product research and development. He helped to develop some of the industries most novel innovative products; high dose inhaled Cromones, Pulmozyme, Exubera and Tobi Podhaler. He has served as Chief Technical Officer and General Manager at number of respiratory drug delivery companies and currently serves on the boards of several innovative companies on inhaled drug delivery.
JF
Guest
Jim Fink
urrently serves as Chief Scientific Officer for Aerogen Pharma Corporation in San Mateo, CA and Senior Fellow of Aerosol Device Development for Dance Biopharm in Brisbane, CA. Dr. Fink is an Adjunct Professor of Respiratory Therapy at Rush Medical School, Chicago, Texas State University and Visiting Professor, Department of Physical therapy, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil (CNPq 400801/2013-2). A respiratory care clinician, supervisor, manager, educator and researcher for 45+ years with the past 25 years dedicated to understanding aerosol device/patient interface and design in both critical care and ambulatory settings.
JP
Guest
John Patton
John Patton is the Executive Chairman, Co-Founder, and Chief Scientific Officer at Inhale Biologics Inc. He previously led Genentech’s first Drug Delivery group and co-founded several pioneering life sciences companies on inhaled insulin. John now focuses on developing inhaled biologics and advancing novel therapeutic delivery approaches that expand treatment options for patients worldwide.

What is Great ISAMs?

About the past congresses of the international society of aerosols in medicine (ISAM). Working our way back from 2025 to the first congress in 1974. Interviewing organizers and visitors. Hosted by Wilbur de Kruijf, ISAM board member.